# WallFlex Biliary Fully Covered (FC) Benign Stricture Study

> **NCT01014390** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 187 (actual)

## Conditions studied

- Biliary Stricture

## Interventions

- **DEVICE:** WallFlex Biliary RX Fully Covered Stent System

## Key facts

- **NCT ID:** NCT01014390
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-11
- **Final completion:** 2017-11
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2020-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01014390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01014390, "WallFlex Biliary Fully Covered (FC) Benign Stricture Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01014390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*